Table 2 Correlation between UPLA1 expression and clinicopathological characteristics.
From: Novel lncRNA UPLA1 mediates tumorigenesis and prognosis in lung adenocarcinoma
Variables | UPLA1 expression | Total | χ2 value | P value | |
|---|---|---|---|---|---|
Low | High | ||||
Age(year) | 1.818 | 0.178 | |||
<60 | 22 | 23 | 45 | ||
å =60 | 18 | 33 | 51 | ||
T stage | 7.554 | 0.006 | |||
T1/T2 | 34 | 36 | 70 | ||
T3/T4 | 4 | 20 | 24 | ||
Sex | 0.392 | 0.531 | |||
Female | 16 | 26 | 42 | ||
Male | 24 | 30 | 54 | ||
TNM stage | 14.890 | 0.000 | |||
Ι/II | 36 | 29 | 65 | ||
III/IV | 4 | 26 | 30 | ||
N stage | 4.176 | 0.041 | |||
N0 | 23 | 20 | 43 | ||
N1/N2/N3 | 17 | 35 | 52 | ||
M stage | 0.722 | 0.396 | |||
M0 | 40 | 55 | 95 | ||
M1 | 0 | 1 | 1 | ||
Grade | 0.000 | 1.000 | |||
I/II | 25 | 35 | 60 | ||
III | 15 | 21 | 36 | ||
